Gaurav Sutrave

Westmead, NSW, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis.

Journal: Clinical pharmacokinetics
Published: April 21, 2026

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Prime editing enables drug-controllable T-cell therapies with clinical immunosuppression.

Journal: Blood
Published: January 12, 2026

Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR-T Cell Recipients-PART 2: Antiviral Therapy and Virus-Specific T Cell Therapy for HCMV in Allo-HSCT.

Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR-T Cell Recipients-PART 2: Antiviral Therapy and Virus-Specific T Cell Therapy for HCMV in Allo-HSCT.

Journal: Reviews in medical virology
Published: November 12, 2025

Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune Response.

Human Cytomegalovirus Infection in Haematopoietic Stem Cell Transplant Recipients and CAR T Cell Recipients - PART 1: Risk Factors, Clinical Impact and Immune Response.

Journal: Reviews in medical virology
Published: November 12, 2025

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Voriconazole therapy and CYP2C19 phenotype: identifying patients who may need alternative antifungal therapy.

Journal: The Journal of antimicrobial chemotherapy
Published: October 26, 2025

Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers.

Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers.

Journal: Cytotherapy
Published: December 11, 2023

A Single Center Review of Patients Undergoing High-Dose Chemotherapy for Relapsed Germ-Cell Tumors.

A Single Center Review of Patients Undergoing High-Dose Chemotherapy for Relapsed Germ-Cell Tumors.

Journal: Asia-Pacific journal of clinical oncology
Published: September 25, 2023

Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.

Early Stage Professionals Committee proceedings from the International Society for Cell & Gene Therapy 2022 Annual Meeting.

Journal: Cytotherapy
Published: December 22, 2022

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.

Combining CD34+ stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant.

Journal: American journal of hematology
Published: May 03, 2022

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

Third-party CMV- and EBV-specific T-cells for first viral reactivation after allogeneic stem cell transplant.

Journal: Blood advances
Published: January 19, 2022

Characterizing piggyBat-a transposase for genetic modification of T cells.

Characterizing piggyBat-a transposase for genetic modification of T cells.

Journal: Molecular therapy. Methods & clinical development
Published: October 31, 2021

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograft.

Journal: Bone marrow transplantation
Published: February 10, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026